RecruitingPhase 3Drug trialRole of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary SyndromeGirls and women 12-35 years old with obesity and polycystic ovarian syndrome who are on or off metformin, will receive a glucagon like peptide-1 receptor agonist intervention for 10 months to induce metabolic changes, weight loss and improve reproductive abnormalities.